Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular Disorders
Protein arginine methyltransferases (PRMTs) are a family of enzymes that catalyze the methylation of arginine residues on target proteins, thereby mediating a diverse set of intracellular functions that are indispensable for survival. Indeed, full-body knockouts of specific PRMTs are lethal and PRMT...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-11-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphys.2017.00870/full |
_version_ | 1828475272559591424 |
---|---|
author | Derek W. Stouth Tiffany L. vanLieshout Nicole Y. Shen Vladimir Ljubicic |
author_facet | Derek W. Stouth Tiffany L. vanLieshout Nicole Y. Shen Vladimir Ljubicic |
author_sort | Derek W. Stouth |
collection | DOAJ |
description | Protein arginine methyltransferases (PRMTs) are a family of enzymes that catalyze the methylation of arginine residues on target proteins, thereby mediating a diverse set of intracellular functions that are indispensable for survival. Indeed, full-body knockouts of specific PRMTs are lethal and PRMT dysregulation has been implicated in the most prevalent chronic disorders, such as cancers and cardiovascular disease (CVD). PRMTs are now emerging as important mediators of skeletal muscle phenotype and plasticity. Since their first description in muscle in 2002, a number of studies employing wide varieties of experimental models support the hypothesis that PRMTs regulate multiple aspects of skeletal muscle biology, including development and regeneration, glucose metabolism, as well as oxidative metabolism. Furthermore, investigations in non-muscle cell types strongly suggest that proteins, such as peroxisome proliferator-activated receptor-γ coactivator-1α, E2F transcription factor 1, receptor interacting protein 140, and the tumor suppressor protein p53, are putative downstream targets of PRMTs that regulate muscle phenotype determination and remodeling. Recent studies demonstrating that PRMT function is dysregulated in Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), and amyotrophic lateral sclerosis (ALS) suggests that altering PRMT expression and/or activity may have therapeutic value for neuromuscular disorders (NMDs). This review summarizes our understanding of PRMT biology in skeletal muscle, and identifies uncharted areas that warrant further investigation in this rapidly expanding field of research. |
first_indexed | 2024-12-11T06:11:22Z |
format | Article |
id | doaj.art-292cfbf765b845d38b0c763c7575bfab |
institution | Directory Open Access Journal |
issn | 1664-042X |
language | English |
last_indexed | 2024-12-11T06:11:22Z |
publishDate | 2017-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Physiology |
spelling | doaj.art-292cfbf765b845d38b0c763c7575bfab2022-12-22T01:18:07ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2017-11-01810.3389/fphys.2017.00870304058Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular DisordersDerek W. StouthTiffany L. vanLieshoutNicole Y. ShenVladimir LjubicicProtein arginine methyltransferases (PRMTs) are a family of enzymes that catalyze the methylation of arginine residues on target proteins, thereby mediating a diverse set of intracellular functions that are indispensable for survival. Indeed, full-body knockouts of specific PRMTs are lethal and PRMT dysregulation has been implicated in the most prevalent chronic disorders, such as cancers and cardiovascular disease (CVD). PRMTs are now emerging as important mediators of skeletal muscle phenotype and plasticity. Since their first description in muscle in 2002, a number of studies employing wide varieties of experimental models support the hypothesis that PRMTs regulate multiple aspects of skeletal muscle biology, including development and regeneration, glucose metabolism, as well as oxidative metabolism. Furthermore, investigations in non-muscle cell types strongly suggest that proteins, such as peroxisome proliferator-activated receptor-γ coactivator-1α, E2F transcription factor 1, receptor interacting protein 140, and the tumor suppressor protein p53, are putative downstream targets of PRMTs that regulate muscle phenotype determination and remodeling. Recent studies demonstrating that PRMT function is dysregulated in Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), and amyotrophic lateral sclerosis (ALS) suggests that altering PRMT expression and/or activity may have therapeutic value for neuromuscular disorders (NMDs). This review summarizes our understanding of PRMT biology in skeletal muscle, and identifies uncharted areas that warrant further investigation in this rapidly expanding field of research.http://journal.frontiersin.org/article/10.3389/fphys.2017.00870/fullprotein arginine methyltransferaseskeletal musclein vivocell culturephenotype |
spellingShingle | Derek W. Stouth Tiffany L. vanLieshout Nicole Y. Shen Vladimir Ljubicic Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular Disorders Frontiers in Physiology protein arginine methyltransferase skeletal muscle in vivo cell culture phenotype |
title | Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular Disorders |
title_full | Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular Disorders |
title_fullStr | Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular Disorders |
title_full_unstemmed | Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular Disorders |
title_short | Regulation of Skeletal Muscle Plasticity by Protein Arginine Methyltransferases and Their Potential Roles in Neuromuscular Disorders |
title_sort | regulation of skeletal muscle plasticity by protein arginine methyltransferases and their potential roles in neuromuscular disorders |
topic | protein arginine methyltransferase skeletal muscle in vivo cell culture phenotype |
url | http://journal.frontiersin.org/article/10.3389/fphys.2017.00870/full |
work_keys_str_mv | AT derekwstouth regulationofskeletalmuscleplasticitybyproteinargininemethyltransferasesandtheirpotentialrolesinneuromusculardisorders AT tiffanylvanlieshout regulationofskeletalmuscleplasticitybyproteinargininemethyltransferasesandtheirpotentialrolesinneuromusculardisorders AT nicoleyshen regulationofskeletalmuscleplasticitybyproteinargininemethyltransferasesandtheirpotentialrolesinneuromusculardisorders AT vladimirljubicic regulationofskeletalmuscleplasticitybyproteinargininemethyltransferasesandtheirpotentialrolesinneuromusculardisorders |